论文部分内容阅读
目的分析高血压脑出血继续出血的致病因素。方法回顾性分析167例高血压脑出血患者的临床资料,其中高血压脑出血继续出血患者26例。分析高血压脑出血继续出血的致病因素。结果继续出血患者血肿形态不规则22例,未继续出血患者5例;继续出血患者卒中病史23例,未继续出血患者8例;继续出血患者慢性肝病史7例,未继续出血患者0例;继续出血患者长期饮酒20例,未继续出血患者12例;继续出血患者凝血功能障碍及服用抗凝剂10例,未继续出血患者2例。继续出血与血肿形态不规则、既往有卒中病史、慢性肝病史、长期饮酒、凝血功能障碍及服用抗凝剂等有关(P<0.05),与年龄、性别无关。结论临床上高血压脑出血继续出血的发生是患者病情加重的主要原因,其相关因素有血肿的形态、既往有卒中病史、慢性肝病史、长期饮酒、凝血功能障碍及服用抗凝剂等,对于继续出血的患者应该尽快治疗,同时选择合适的治疗方法 ,减少对患者的伤害,降低致死率和致残率。
Objective To analyze the risk factors of hemorrhage due to hypertensive intracerebral hemorrhage. Methods The clinical data of 167 patients with hypertensive intracerebral hemorrhage were retrospectively analyzed. Among them, 26 patients had hemorrhage with hypertensive intracerebral hemorrhage. Analysis of hypertensive intracerebral hemorrhage to continue the risk factors. Results 22 patients with hematoma continued to hemorrhage and 5 patients did not continue to hemorrhage; 23 patients with hemorrhage continuing stroke, 8 patients without hemorrhage; 7 patients with chronic liver disease continuing to hemorrhage and 0 patients without hemorrhage; Long-term bleeding in patients with bleeding in 20 cases, 12 patients did not continue to hemorrhage; continued bleeding in patients with coagulation disorders and taking anticoagulants in 10 cases, 2 patients did not continue to hemorrhage. Continued bleeding and irregular hematoma, history of previous stroke, history of chronic liver disease, long-term drinking, coagulation disorders and taking anticoagulants (P <0.05), has nothing to do with age and gender. Conclusions The occurrence of continuous hemorrhage in patients with hypertensive intracerebral hemorrhage is the main reason for the exacerbation of hypertensive intracerebral hemorrhage. The related factors include the morphology of hematoma, the history of stroke, the history of chronic liver disease, long-term alcohol consumption, coagulation dysfunction and anticoagulant therapy. Patients who continue to bleed should be treated as soon as possible, while choosing the appropriate treatment to reduce the harm to patients and reduce mortality and morbidity.